Heterozygous loss-of-function mutations in SHANK2 are associated with autism spectrum disorder (ASD). We generated cortical neurons from induced pluripotent stem cells derived from neurotypic and ASD-affected donors. We developed sparse coculture for connectivity assays where SHANK2 and control neurons were differentially labeled and sparsely seeded together on a lawn of unlabeled control neurons. We observed increases in dendrite length, dendrite complexity, synapse number, and frequency of spontaneous excitatory postsynaptic currents. These findings were phenocopied in gene-edited homozygous SHANK2 knockout cells and rescued by gene correction of an ASD SHANK2 mutation. Dendrite length increases were exacerbated by IGF1, TG003, or BDNF, and suppressed by DHPG treatment. The transcriptome in isogenic SHANK2 neurons was perturbed in synapse, plasticity, and neuronal morphogenesis gene sets and ASD gene modules, and activity-dependent dendrite extension was impaired. Our findings provide evidence for hyperconnectivity and altered transcriptome in SHANK2 neurons derived from ASD subjects. Supplementary Fig. 4c ). SHANK2 protein level at 4 weeks was halved in neurons from R841X and DEL and absent in KO cells (Supplementary Fig. 5a) but restored in R841X-C ( Supplementary  Fig 3d) . SHANK2 protein plateaued after 4 weeks of differentiation, demonstrating expression before and during the onset of synaptogenesis in vitro 12,13 and developmental regulation in human neurons ( Supplementary Fig. 5b ). Thus, the differentiation protocol produces SHANK2-expressing control and mutant cortical neurons suitable for connectivity studies.
These authors contributed equally: Kirill Zaslavsky, Wen-Bo Zhang. *e-mail: michael.salter@sickkids.ca; jellis@sickkids.ca I nduced pluripotent stem cell (iPSC) models of severe syndromic forms of ASD and engineered human embryonic stem cell knockouts (KOs) of ASD candidate genes provide evidence for reduced synaptic function of cortical neurons in vitro [1] [2] [3] [4] [5] . Despite these initial findings, extensive heterogeneity among neurons generated from different iPSC lines has come to be a widely acknowledged issue in the field 6, 7 . This experimental variability hinders accurate modeling of altered connectivity of affected neurons relative to controls and may prevent discovery of all but the most extreme phenotypes. To overcome variability caused by neuronal density, Shcheglovitov and colleagues utilized equal coculture of differentially labeled control and Phelan-McDermid syndrome iPSC-derived neurons on a bed of rat cortical astrocytes 6 . Here, we adapted this approach to define changes in neuron morphology and electrophysiology by sparse seeding labeled control and mutant neurons on a lawn of unlabeled control neurons and mouse astrocytes. We applied these sparse coculture for connectivity (SparCon) assays to iPSC-derived neurons from non-syndromic ASD cases with mutations in the scaffolding protein SHANK2 (SH3-and multiple ankyrin repeats protein 2).
Generation of iPSCs from SHANK2 ASD families and by isogenic SHANK2 KO or rescue
We generated iPSCs from two families with ASD-affected males with SHANK2 haploinsufficiency (Fig. 1a) . One subject harbors a non-sense mutation (R841X) and the other a 66-kilobase deletion (DEL) that causes a frameshift and premature stop 8 . Whole genome sequencing revealed no additional variants of potential clinical relevance beyond those already reported in the literature for SHANK2 DEL (CHRNA7 duplication and ARHGAP11B deletion) 9 . Multiple lines were isolated from both subjects, and control lines were generated from three unaffected parents and one unrelated individual ( Fig. 1a and Supplementary Fig. 1 ). We generated an isogenic CRISPR-Cas9n-edited homozygous KO from the unrelated CTRL1 (previously reported as 19-2) using a selection-free strategy based on sequential enrichment of targeted cells ( Supplementary Fig. 2 ) 10 . Finally, we CRISPR-Cas9n edited R841X followed by Cre-excision of a floxed neomycin-resistance gene to isolate an isogenic corrected line (R841X-C) ( Supplementary Fig 3) . Whole genome sequencing confirmed correct targeting (Supplementary Table 1 ) and did not reveal any non-allelic alterations in close proximity to possible guide RNA (gRNA) binding sites predicted by in silico means 10 . More distant off-target effects in the rest of the genome were not excluded by this analysis. Short tandem repeat (STR) profiling confirmed that R841X-C was derived from R841X (Supplementary Table 2) .
We used an embryoid body-based differentiation protocol to generate SOX1
+ neural precursor cells (NPCs) that were expanded and frozen for use in multiple experiments 11 (Supplementary Fig. 4a, b) . The NPCs gave rise to neurons of mixed cortical SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons layers ( Supplementary Fig. 4c ). SHANK2 protein level at 4 weeks was halved in neurons from R841X and DEL and absent in KO cells (Supplementary Fig. 5a ) but restored in R841X-C ( Supplementary  Fig 3d) . SHANK2 protein plateaued after 4 weeks of differentiation, demonstrating expression before and during the onset of synaptogenesis in vitro 12, 13 and developmental regulation in human neurons ( Supplementary Fig. 5b ). Thus, the differentiation protocol produces SHANK2-expressing control and mutant cortical neurons suitable for connectivity studies.
Establishment of SparCon assays on SHANK2 and control neurons
We observed that directed differentiation produced neurons with variable cell densities in monocultures ( Supplementary Fig. 6 ), and reasoned that the final cell type composition or maturity of monocultures may also differ over the prolonged experimental time course necessary for synaptic development in human neurons. The accompanying differences in neuronal synaptogenesis, which is modulated by extracellular cues, may increase experimental noise and obscure biological differences in connectivity between control and mutant neurons. In principle, maximal consistency would result if a controlled synaptogenic environment was used in every experiment. This is the foundation of the SparCon assay, in which a small number of differentially labeled pairs of SHANK2 mutant and control neurons are sparsely seeded together onto a lawn of unlabeled control neurons.
To set up SparCon assays (Fig. 1a) , we transduced 3-week-old differentiating control and SHANK2 mutant neurons with lentiviruses expressing either red (mKO2 or mKate2) or green (GFP) fluorescent proteins driven by the CaMKIIα promoter, which further enriches for SHANK2-expressing neurons 4 and has been shown by single-cell RNA sequencing (RNA-seq) to mark well-differentiated excitatory glutamatergic neurons differentiated in vitro from iPSC 14 . Following a 1-week recovery, differentially labeled control and SHANK2 mutant neurons were sparsely seeded (at 2% of total neurons each) onto an unlabeled control lawn (96% of total neurons) on a layer of mouse astrocytes to promote synaptogenesis over 5 weeks (Fig. 1b) . We established 14 experimental batches of neurons with multiple (3-12) cover slips from each batch of differentiated neurons. A single batch was used to test each SHANK2 genotype. Neurons from 3 lines each of R841X and DEL were cocultured with 2-5 control lines (including at least 1 parental control) in pairs using an experimental design in which the reporter used to mark each genotype was blinded. The KO was compared with its isogenic CTRL1 and one unrelated control line, and R841X was compared with the isogenic corrected R841X-C (Supplementary Tables 3-6 ). In addition to being cultured on the wild-type (WT) control lawns, the R841X isogenic pair was also evaluated on unlabeled R841X mutant lawns to control for cell non-autonomous effects of the lawns. After a total of 9 weeks of differentiation, marked neurons expressed cortical and excitatory markers 4 ( Supplementary Fig. 7a ). These neurons were electrophysiologically active using physiological salt solutions in intracellular and extracellular environments and capable of generating action potentials ( Supplementary Fig. 7b ). SHANK2 mutant neurons did not differ from controls in intrinsic membrane properties (Supplementary Fig. 7c ). Detailed SparCon methods, controls, and validation of normalization of SHANK2 −/− KO line, and 1 engineered isogenic SHANK2 correction line (R841X-C). For d, SHANK2 R841X neurons (total n = 595) were compared with isogenic R841X-C neurons (total n = 651) in all treatment conditions. Total number of neurons = 1,186. See Supplementary  Tables 7 and 8 for details of all treatment comparisons and relevant statistics. Means ± s.e.m. plotted; *P < 0.05, **P < 0.01, ***P < 0.005; AndersonDarling k-samples test for a,b, and d and two-way ANOVA for c.
mutants to control cells in the same well are described (see .
Because sparse seeding allows visualization of entire marked neurons by immunostaining, we directly measured connectivity as total synapse number per neuron by counting puncta of Synapsin-1 (SYN1), a universal marker of mammalian cortical synapses 15 previously used to estimate synapse density in iPSC-derived neurons 3, 5 , along fluorescently labeled neuronal dendrites (Fig. 1c) . This was accompanied by simultaneous acquisition of morphological data (dendrite length and complexity) from the same cells (Fig. 1d) and spontaneous excitatory postsynaptic current (sEPSC) recordings (Fig. 1e) , providing a high level of detail on connectivity of human stem cell-derived neurons.
increased synapse number and dendrite length in SHANK2 mutant human neurons SYN1 puncta localized on the labeled neurons revealed a significant increase in total synapse number in all SHANK2 mutants after SparCon normalization (Fig. 2a) , showing that lowered SHANK2 dosage causes an increase in synaptic connections. Using the same neurons, we also found increases in normalized dendrite length in all SHANK2 mutants (Fig. 2b) . Consistent with a previous report on SHANK2 knockdown in rat neurons in vitro 16 , we found that normalized dendrite branching complexity, measured by Sholl analysis, was increased in all SHANK2 mutants (Fig. 2c) . When R841X was compared with R841X-C seeded on an unlabeled R841X neuron lawn thereby mimicking the in vivo situation, similar-fold effects on synapse number, dendrite length, and branching complexity were seen (Fig. 2a-c) , demonstrating that these effects were cell autonomous and not due to the presence of control neurons in the lawn.
The statistical summary of normalized and raw data comparisons is shown in Supplementary Table 7 and Supplementary Fig. 12a ,b. Taken together, these findings indicate that lowered SHANK2 dosage increases the total synapse number resulting in neuronal hyperconnectivity, which is partly driven by increases in dendrite length and complexity.
To test pathways known to impact dendrite growth or rescue function in SHANK3 mutant human neurons KO line. Mean ± s.e.m. plotted; NS, not significant, *P < 0.05, **P < 0.01, ***P < 0.005; Anderson-Darling k-samples test. A detailed statistical summary including exact P values can be found in Supplementary Table 9 .
compared with R841X-C exhibited an increase in sEPSC amplitude on both the control lawn and mutant (R841X) lawn, providing further evidence that SHANK2 regulates the strength of synaptic connections in the R841X background under basal conditions (Fig. 3b) . The statistical summary of normalized and raw data comparisons is shown in Supplementary Table 9 and Supplementary Fig. 12c,d . In addition, when we increased sEPSC frequency with BDNF 18 , no significant difference was observed in R841X sEPSC amplitude ( Supplementary Fig. 14) .
We found a striking increase in sEPSC frequency across all SHANK2 genotypes under basal conditions (Fig. 3c) and with BDNF treatment (Supplementary Fig. 14b ). Moreover, R841X compared with R841X-C exhibited increased sEPSC frequency when grown on both control and mutant lawns (Fig. 3c) . Finally, as deficiency of SHANK3 was previously shown to cause dysfunction of hyperpolarization-activated cyclic nucleotide-gated channel proteins forming I h -channels 3 , we measured I h currents in SHANK2 mutant neurons. Acute application of the I h -channel blocker ZD7288 resulted in no significant change between genotypes in the firing frequency of action potentials evoked by injection of current steps (Supplementary Table 6 and Supplementary Fig. 15 ). These data demonstrate that heterozygous loss of function in SHANK2 is solely responsible for the hyperconnectivity phenotype observed in neurons derived from subjects with ASD and that SHANK2 does not disturb I h channels. Given that a common population of neurons in the lawn in SparCon assays drives the input to both control and mutant neurons, increased sEPSC frequency is consistent with the increase we observed in synapse number in the neurons lacking SHANK2. Taken together, our data provide strong evidence that reduced dosage of SHANK2 increases synaptic connectivity.
Perturbed neurodevelopment gene sets and activitydependent dendrite extension
To investigate molecular perturbations that occur in SHANK2 neurons, we performed RNA-seq at timepoints relevant for the SparCon assay. R841X and R841X-C neuron monocultures at the 4-week timepoint and after 5 more weeks maturing on mouse astrocytes were subjected to magnetic activated cell sorting (MACS) to deplete contaminating human NPCs and astrocytes 19 . Duplicate RNA samples from each of two independent differentiations were sequenced. At 4 weeks, we found similar levels of cortical layers and neuronal subtype markers ( Fig. 4a and Supplementary Tables 10 and 11), suggesting that cortical cell identity is largely similar when SparCon cocultures are established. After the subsequent 5 weeks of maturation, increases in several cell identity markers and synapse genes were detected in 9-week R841X neurons. At 4 weeks 3,029 genes were significantly altered, and 2,809 genes were perturbed at 9 weeks ( Fig. 4b and Supplementary Table 11 ). However, only 724 genes were differentially expressed in common at these 2 timepoints, suggesting that SHANK2 mutant neurons diverge from controls during development. Consistent with this idea, continuous gene set enrichment analysis 20 at 4 weeks showed that R841X cultures are associated with gene sets related to cell cycle, DNA replication, mitochondrial function, and transcriptional and translation regulation, whereas R841X-C cultures are associated with greater expression in ion channel and synapse function genes ( Fig. 4b and Supplementary  Table 12 ). At 9 weeks, following 5 weeks of culture with mouse astrocytes, there is a significant upregulation of gene sets associated with neuronal differentiation, neurite development, and synapse function in R841X neurons. Upregulation of gene sets associated with translation and mitochondrial function persists at 9 weeks in R841X neurons, whereas RNA processing changes are equivocal (Fig. 4b) . In contrast to changes at 4 weeks, there is a relative suppression of cell cycle-related genes in 9-week-old R841X neurons. The latter gene sets would be predicted to change neuronal density in monocultures contributing to the variability we previously observed ( Supplementary Fig 6) .
Given that GRIN2B, GRM1, and GRM5 transcripts were elevated at 9 weeks in R841X (Fig. 4a) , we explored potential changes in genes and functional processes that are regulated by neuronal activity, development, and synaptic plasticity. We observed no enrichment among genes previously shown to be activated in response to activity in iPSC-derived neurons 21 ( Supplementary Fig 16a) . However, synapse assembly and chemical synaptic transmission gene sets were significantly enriched among upregulated differentially expressed genes (DEGs) in R841X neurons (Fig. 4c) . Consistent with this, the upregulation of glutamate receptor signaling genes in R841X cells suggested that hyperconnectivity may be in part supported by higher expression of glutamate receptors. Similarly, upregulation of genes involved in neuronal projection development in R841X neurons parallels our observation of increased dendrite length and complexity (Fig. 4c) . As a possible functional consequence of these alterations, there was a striking upregulation of genes associated with synaptic plasticity (Fig. 4d) . Consistent with this idea, a high proportion of Fragile-X mental retardation protein (FMRP) targets 22 were increased in R841X neurons, although we found no obvious enrichment of translation-associated genes (Fig. 4d) .
We therefore tested how R841X neurons respond to activity. Live imaging experiments assaying KCl-induced dendrite extension revealed that GFP-marked dendrites were already longer at baseline in R841X compared with control neurons at week 6, but only control neurons extended further at 500 minutes after activation ( Fig. 4e and Supplementary Fig 17) . We also performed SparCon experiments testing chronic DHPG activation of mGluR, which regulates FMRP-dependent translation, from weeks 5-9 at a concentration that had no effect on R841X-C neurons. Dendrite length in R841X treated neurons was significantly reduced compared with R841X DMSO controls and equivalent to R841X-C (Fig. 4e) . These findings show that acute activity-dependent dendrite extension was compromised in R841X neurons in vitro. However, chronic DHPG exposure normalized dendrite length, demonstrating that the dendrite phenotype can be suppressed in R841X neurons during this developmental period, and may be related to increased expression of FMRP targets.
We next examined whether gene expression changes in R841X neurons could be related to ASD generally. When modules of coregulated genes during neurodevelopment defined by Parikshak et al. 23 and Willsey et al. 24 were examined in our RNA-seq data ( Fig. 4f and Supplementary Fig 16b,c) , we observed that several previously described ASD-associated modules associated with mid-fetal development M16 and M17 23 and localized to the prefrontal and primary motor-somatosensory cortex 24 were significantly enriched among upregulated DEGs at 9 weeks. ASD module M3, which is associated with early fetal development, was enriched among upregulated DEGs at 4 weeks. Overall, these findings demonstrate that transcription is deeply perturbed in SHANK2 neurons and that these changes are enriched in specific gene sets related to neurodevelopment and ASD.
Discussion
Our findings show that human neurons with ASD-associated haploinsufficeint SHANK2 mutations make more functional excitatory connections relative to controls, and this phenotype is distinct from the lowered connectivity associated with mutations in SHANK3 or other ASD-associated genes [2] [3] [4] . The presence of the same hyperconnectivity phenotype in homozygous KO neurons and its reversion in gene-corrected R841X-C neurons demonstrate that SHANK2 mutations cause this phenotype. The experiments we report simultaneously evaluated the total synapse number, dendrite length, and complexity of SHANK2 neurons and demonstrated increases in these measures. We found small increases in sEPSC amplitude particularly in the three R841X lines compared with family and unrelated controls, and in the isogenic pair evaluations of R841X and KO neurons, but not in the three DEL lines. Large increases were observed on sEPSC frequency in all genotypes, demonstrating that this measure of connectivity was most prominently and reproducibly affected. IGF1, TG003, and BDNF treatment exacerbated Supplementary Table 10 for all marker gene expression fold change values and relevant statistics. b, Number of differentially expressed genes in pie charts, and enrichment of neurodevelopment, translation, and cell cycle gene sets in R841X neurons. c, Volcano plots and examples of differentially expressed genes in gene sets related to synapse function and neuron projection development. d, Volcano plots and examples of differentially expressed genes in gene sets related to synaptic plasticity and translation. Highlighted points have absolute log 2 fold change > 1.25 and P adj < 0.05. e, Starting dendrite length is greater in R841X neurons, which have impaired acute KCl activity-dependent dendrite extension (SHANK2 R841X n = 47 from lines no. 2, no. 5, and no. 13) versus CTRL (n = 44 from CTRL1 line no. 2 and CTRL3 line no. 39), and rescue of R841X dendrite length by chronic DHPG treatment (R841X-C DMSO n = 141, R841X-C + DHPG n = 65, R841X DMSO n = 120, R841X + DHPG n = 76). Mean ± s.e.m. plotted; *P < 0.05; Anderson-Darling k-samples test. f, Enrichment of M16 and M17 ASD gene modules in 9-week and the M3 ASD module in 4-week R841X neurons. For a-d and f, n = 4 independent differentiations for both genotypes at each timepoint. *P adj < 0.05, **P adj < 0.01, ***P adj < 0.005; Wald test with Benjamini-Hochberg correction for multiple testing.
the dendrite length in both mutant R841X and corrected R841X-C neurons, suggesting that these modes of regulating global translation are not contributing to the altered morphology. Our results provide further evidence that SHANK2 functions in early neuronal development 25 and serves an important role as a suppressor of dendrite branching 26 . SparCon normalization overcame the challenge presented by variable cell densities in monocultured SHANK2 and control neurons that result from genetic background or batch effects 7, 27 . We showed cell autonomous effects by assessing morphology and electrophysiology of R841X on control and mutant lawns. In future experiments, lawns could be engineered to contain specific excitatory subtypes by Ngn2 overexpression 28 or to express optically or chemically gated modulators of activity that expand the range of possible testable phenotypes. Moreover, SparCon can be adapted to use other cell type-specific promoters such as hvGAT to selectively label inhibitory neurons 29 or GDAP1L1 30 to restrict analyses to neurons of similar age and electrophysiological properties. As new approaches are developed to specify stem cell-derived neurons or mature them to later stages, our isogenic SHANK2 and control iPSC lines will be a valuable resource for examining the dynamics of connectivity and circuitry of human neurons during development and disease.
The phenotype of SHANK2 human neurons contrasts with variable findings reported for Shank2 and Shank3 mouse neurons. Two different Shank2 null mice with no evidence of Shank2 protein expression exhibited either no change or a decrease in miniature EPSC frequency in the hippocampus, a site of relatively high Shank2 protein level 31, 32 . One of those mice, Shank2 ex7
, which is most similar to our engineered SHANK2 KO line, had enhanced LTP 31 and decreased synapse maturation 33 . Consistent with this, RNA-seq data in our cortical cultures showed a relative upregulation of GRIN2B in R841X neurons, a feature of immature synapses. Similarly, knockdowns of Shank2 in vitro in rodent neurons have typically led to 20-50% decreases in synapse density with a concomitant increase in dendrite complexity 16, 34 . Only the shared increase in dendrite complexity was found in our human SHANK2 mutant neurons, possibly due to a species-specific difference in SHANK2 function, a difference in the cell types assessed 35 , or a difference in developmental timepoints at which the phenotypes were assayed. Concordant with the latter idea, AMPAR miniature EPSC hyperconnectivity was found in Shank3b null mice shortly after birth and disappeared at postnatal day 60 (ref. 36 ), suggesting the existence of a critical developmental window of hyperconnectivity to be found after SHANK mutation. Furthermore, the relatively high prevalence of non-synonymous SHANK2 mutations in ASD, their association with other disorders such as schizophrenia, as well the variable phenotypes reported for different Shank2 mouse mutants suggest a broader repertoire of possible functional alterations in SHANK2 that contribute to neuropsychiatric disorders 37 . In this context, our results contribute to defining the neuronal phenotype associated with reduced SHANK2 dosage, an expected consequence of deletions and non-sense mutations that show a near-complete penetrance of ASD in humans 9, 38, 39 . SHANK2 is a postsynaptic density scaffolding protein that anchors a protein complex connecting NMDAR, AMPAR, and mGluR receptors 40 , which participate in pathways that regulate activity-dependent transcription and translation 41 . Concordant with this, our RNA-seq results show consistent increases in NMDA receptor subunit and mGluR transcripts, as well as enrichment of gene sets important for synapse plasticity and targets of FMRP, a well-known regulator of local activity-dependent translation at dendrites and synapses. Curiously, Fmr1 KO mice demonstrate early hyperconnectivity in the medial prefrontal cortex 42 , similar to our findings in SHANK2 mutant human neurons. Impaired acute activity-dependent dendrite extension coupled with increased basal dendrite length in mutant neurons suggests that neurotypic levels of SHANK2 suppress excess dendritogenesis during development and enable acute activity-dependent extension. In contrast, at haploinsufficient SHANK2 levels, dendrite extension is no longer suppressed and acute activity-dependent growth regulation is lost. Further highlighting the critical role of activity-dependent translation in this phenotype, chronic agonism of mGluRs with DHPG in SparCon cocultures differentially suppressed dendrite length in R841X neurons relative to controls. Here, return of dendrite length to WT levels suggests that mGluR activation of SHANK2 mutant neurons can rescue the dendrite phenotype. These findings, along with enrichment of gene sets regulating dendrite morphology in RNA-seq, support the idea that SHANK2 haploinsufficiency disrupts the intricate interplay between synapse formation and dendritogenesis critical to appropriate establishment of neuronal connectivity 43 . It is possible that DHPG may act by enhancing synapse elimination 44 , which may concomitantly destabilize nascent neurites during development and result in shorter dendrite length.
Enrichment of ASD-associated modules among upregulated DEGs at 4 and 9 weeks suggests that the phenotypes we report here may be a general feature of ASD. The M3 module harbors cell cycle and chromatin/transcriptional regulators expressed in early fetal development and is upregulated relatively early at 4 weeks in SHANK2 mutant neurons. In contrast, upregulated DEGs at 9 weeks are enriched in modules M16 and M17 containing synaptic proteins and to the prefrontal and primary motor-somatosensory cortex modules during mid-fetal development. The abundance of risk genes for idiopathic ASD in these modules suggests that lowered SHANK2 dosage triggers an ASD-specific transcriptional program. Our findings contrast with the downregulation of these modules in human NPCs with knockdown of CHD8 (ref.
45
), another high-risk ASD gene, implying the existence of multiple distinct etiologies that manifest as ASD. Our finding of hyperconnectivity reflects observations of increased synapse density in postmortem ASD brain samples. Previously, this increase was linked to impaired mTORdependent autophagy, leading to a deficit in pruning and hyperconnectivity in teenage years 46 . Here, the alterations in SHANK2 neurons lead to a distinct, early hyperconnected phenotype. Unsuppressed elaboration of the dendritic tree in developing SHANK2 mutant neurons may increase the probability of establishing synaptic connections, leading to functional hyperconnectivity measured as strikingly increased sEPSC frequencies. It is possible that this mechanism applies broadly to ASD cases given the recent observation of increased abundance of SHANK2-AS long non-coding RNA and concurrently lowered SHANK2 protein levels in ASD samples without verified SHANK2 mutations 47 . As further ASD-associated genes are shown to cause hyperconnectivity 48 , it will be important to determine how signaling pathways and common ASD enriched gene modules suppress or activate dendritic and synaptic regulation in excitatory neurons at both the transcriptional and translational levels. It will be crucial to assess the developmental specificity and reversibility of these perturbations to pinpoint druggable candidates that have therapeutic potential for neurodevelopmental disorders.
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Methods

Generation of iPSCs.
All pluripotent stem cell work was approved by the Canadian Institutes of Health Research Stem Cell Oversight Committee. With approval from the SickKids Research Ethics Board, we obtained dermal fibroblasts from skin-punch biopsies at the Hospital for Sick Children, after informed consent was obtained from all subjects in compliance with all relevant ethical regulations. iPSCs were generated by either retroviral reprogramming (CTRL1, CTRL3, CTRL4, SHANK2 R841X) as described 49 or Sendai virus reprogramming (CTRL2, SHANK2 DEL) using the Invitrogen CytoTune-iPS kit. During reprogramming and clonal expansion, iPSC colonies were grown on gelatin-coated plates on a layer of Mitomycin-C inactivated mouse embryonic fibroblasts extracted at embryonic day 12.5 (acquired from Hospital for Sick Children Embryonic Stem Cell Facility) in human embryonic stem cell media (KO DMEM supplemented with 15% KO serum replacement, 1× GlutaMAX, 1× penicillin/streptomycin, 1× non-essential amino acids, 0.5 mM 2-mercaptoethanol, and 10 ng ml −1 basic fibroblast growth factor (bFGF)). At this stage, the cells were passaged manually or with collagenase IV as described. Established iPSC lines were transitioned to plates coated with matrigel and grown in either mTeSR or StemMACS iPS Brew medium. From this point on, the cells were passaged either manually, using Dispase or ReleSR every 5-7 d.
To verify genome integrity, G-band karyotyping was performed by the Centre for Applied Genomics (Hospital for Sick Children) and only iPSC lines without karyotypic abnormalities were used for analyses. To test expression of pluripotency-associated factors OCT4, NANOG, TRA1-60, and SSEA4, immunocytochemistry was performed. To test whether cells were functionally pluripotent in vitro, iPSCs underwent spontaneous differentiation through an embryoid body-based step as described 50 , were fixed, and were stained for expression of endoderm (α-fetoprotein, AFP), mesoderm (smooth muscle actin, SMA), and ectoderm (β3-tubulin, TUBB3). Functional pluripotency in vivo was tested using teratoma assays. iPSC lines were grown in 10-cm matrigel-coated dishes, digested with collagenase IV, and injected into the flanks of 6-week-old NOD/SCID female mice as cell clumps immersed as described 50 . Two months later or when obvious tumors appeared, the mice were killed and the tumors were resected, stained with hematoxylin and eosin, and imaged. All animal work was approved by The Hospital for Sick Children Animal Care Committee and complies with the guidelines established by The Canadian Council of Animal Care.
Generation of SHANK2 KO cells.
Two million iPSCs were nucleofected using the Amaxa Nucleofector II with program B-016 in solution I with 5 μg CRISPR D10A nickase plasmid (Addgene, catalog no. 44720), 2.5 μg each of 2 gRNA cloning plasmids (Addgene, catalog no. 41824) containing paired gRNAs 1 and 2 targeting exon 16 of SHANK2, and 1 μl of 10 μM single-stranded oligodeoxynucleotide (ssODN) containing 2 60-nucleotide-long arms of homology and SHANK2 KO sequence comprised of V5 tag, Mre1 restriction site, and stop codons in all 3 reading frames. Following nucleofection, the cells were distributed in a 96-well plate. Following 2 weeks of growth, one-third of the cells were passed to a new 96-well plate and maintained, one-third were passed to a new 96-well plate and frozen in 90% KOSR/10% DMSO mix with 10 µM ROCK inhibitor, and one-third had gDNA extracted as in ref. 51 . Digital droplet PCR was used to determine the proportion of SHANK2 tag alleles in each well with a Fam-conjugated probe for the SHANK2 WT sequence and Vic-conjugated probe for the SHANK2 KO (Vic tag) sequence. The well with the highest proportion was expanded into a new 96-well plate and the procedure was repeated until wells with 100% SHANK2 tag allele and 0% SHANK2 WT were found. The isolated wells were expanded and the resulting iPSC lines were characterized to assay pluripotency (in vitro via immunocytochemistry (ICC) for pluripotency markers, in vivo via teratoma assays) and karyotyping. Off-target effects were assessed using whole genome sequencing performed by The Centre for Applied Genomics and analyzed as described below.
Gene correction in SHANK2 R841X iPSCs. The pPNT plasmid backbone with a floxed neomycin positive selection cassette and an HSV-TK negative selection cassette was used to generate the targeting plasmid for correction. First, genomic DNA from CTRL2 no. 4 (R841X paternal control) iPSCs was used to amplify a blunt-ended 2,316-base pair (bp) PCR fragment from the affected locus, which was subsequently subcloned into the pCR-Blunt II-TOPO vector using the Zero Blunt PCR Cloning kit (ThermoFisher). Bacterial clones bearing the plasmid with the WT sequence were isolated and their integrity verified using Sanger sequencing.
Following this, a Gibson cloning strategy was used to generate the targeting vector. First, the pPNT plasmid was digested with EcoRI and BamHI enzymes to cut out the floxed neomycin resistance cassette. Both the cassette and the digested plasmid were gel purified. Then, two homology arms were amplified from the blunt-end cloned template fragment with overhangs complementary to the digested pPNT plasmid and to each other containing EcoRI and BamHI restriction enzyme sites in the intronic region for subcloning the floxed neo cassette. The amplified homology arms were combined with the digested pPNT plasmid in a Gibson cloning reaction to generate a plasmid with the negative selection marker HSV-TK and two homology arms separated by a region containing EcoRI and BamHI restriction enzyme sites. The floxed neomycin resistance cassette was subsequently cloned into that region, generating the final targeting plasmid.
To preserve the plasmid during CRISPR-Cas9n-mediated homology-directed repair, target specifically the mutant sequence, and increase recombination efficiency in iPSCs, we generated two pairs of gRNAs for the Cas9n nickase. The first pair targeted the junction between two homology arms such that the PAM site of one of the gRNAs would be contained on the other homology arm and thus prevent digestion of plasmid. The second pair was designed to be specific to the mutant sequence to spare the WT sequence-bearing plasmid and minimize cutting of the WT allele.
Six million iPSCs from the SHANK2 R841X line no. 5 were then nucleofected with 15 μg CRISPR D10A nickase plasmid (Addgene, catalog no. 44720), 1.25 μg each of the 4 gRNA plasmids, and 20 μg of the targeting plasmid. Following nucleofection, the cells were plated on a 10-cm dish and allowed to recover for 3 d, after which the feeding media was supplemented with 25 μg ml −1 G418 every day. The surviving colonies were manually picked into a 96-well plate. Following expansion in the 96-well plate, one-third of the cells were passed to a new 96-well plate and maintained, one-third were passed to a new 96-well plate and frozen in 90% KOSR/10% DMSO mix with 10 µM ROCK inhibitor, and one-third had gDNA extracted as in ref. 51 . Colonies were screened using PCR amplification and XhoI digestion of the targeted region. The mutation causing the premature termination codon in SHANK2 R841X destroys a naturally occurring XhoI restriction site. Because all mutant alleles will fail to digest with XhoI treatment, we picked only those clones whose PCR products were fully digested, signifying the presence of WT sequence at both alleles. These clones were then expanded, and 2 million cells were nucleofected with 10 μg Cre-IRES-Puro plasmid and plated in a 10-cm dish. The cells were subjected to 1 μg ml −1 puromycin on days 2 to 4 to select for transfected cells. The colonies were again picked into a 96-wellplate and expanded. Following expansion in the 96-well plate, one-third of the cells were passed to a new 96-well plate and maintained, one-third were passed to a new 96-well plate and frozen in 90% KOSR/10% DMSO mix with 10 µM ROCK inhibitor, and one-third were passed to another 96-well plate where they were exposed to 25 μg ml −1 G418 for 1 week. Failure to survive under these conditions indicated a high likelihood of excision of the floxed neoymicin cassette. The corresponding iPSC colonies on the non-G418 treated plate were expanded, PCR-sequence verified for WT sequence, subjected to short tandem repeat analysis to rule out contamination with other cell lines (Supplementary  Table 2 ), and karyotyped. Then, western blots with protein lysates from the isolated clones were used to test whether SHANK2 protein levels returned to those seen in control iPSCs and 4-week-old neurons.
Characterization of off-target effects resulting from CRISPR-Cas9n editing.
Genomic positions with designed gRNA sequences matching the human genome (hg38) were downloaded from the CRISPR Design Tool at the Zhang Lab website (http://crispr.mit.edu/). Because our gRNA cloning protocol sets the first 5′ nucleotide as G which is dispensable for specificity, mismatches at that position were ignored. Likewise, mismatches at the PAM sequence were ignored. Sequences with up to three mismatches in the remaining fragments were then selected for analysis. Because hg38 genome may be missing parts of hg19 reference genome that may contain additional gRNA binding sites, the positions of those fragments were remapped to hg19, but did not yield any additional possible binding sites.
Whole genome sequencing was performed on both starting lines and the derived lines at The Centre for Applied Genomics. The reads were mapped using the bwa algorithm (v.0.7.12) 52 , duplicate reads were marked with Picard (v.1.33), and the genome was analyzed with GATK (v.3.4.6) 53 . To verify that the SHANK2 KO (Vic tag) sequence was inserted at the right location, 100 bp of SHANK2 KO sequence was reconstructed in each direction at each locus predicted by the CRISPR Design Tool. The only insertion was found at the on-target site, and reconstruction revealed that it matched the SHANK2 KO (Vic tag) sequence (Supplementary Table 1 ). The sequence was verified by PCR and Sanger sequencing.
To search for off-target SHANK2 KO (Vic Tag) insertions at sites not predicted by the CRISPR Design Tool, GATK (GenotypeConcordance) was used to identify de novo indel and single nucleotide polymorphism (SNP) calls in SHANK2 KO genome with respect to the control genome. Because of the length of the SHANK2 KO sequence, it could have appeared as a series of GATK calls in close proximity to one another. Therefore, all calls occurring within a 200-bp window were grouped, and GATK FastaAlternateReferenceMaker was used to reconstruct the SHANK2 KO sequence within that window to identify any potential insertions. We only found the SHANK2 KO (Vic Tag) insertion at the expected locus.
To determine whether the SNPs/indels unique to the starting line can create additional gRNA binding sites and facilitate off-target mutagenesis, we reconstructed 100 bp of genome sequence of the starting line in both directions at each of the identified unique calls. The gRNA sequences 1 and 2 were then mapped to those sequences using bwa to identify potential gRNA binding sites. Both 1 and 2 gRNAs mapped only to regions containing the exact match of the sequence near the on-target location of SHANK2 exon 16, suggesting an absence of off-target effects caused by CRISPR-Cas9n editing.
To determine whether any SNPs/indels may be attributable to CRISPR-Cas9n editing, we first determined all possible binding positions for gRNAs, tolerating up to five mismatches. Next, we reconstructed 100 bp of sequence in each direction from the binding site in the derived lines. No new SNPs/indels relative to the starting lines were discovered.
The same process was repeated to search for off-target effects during CRISPRCas9n correction of R841X to R841X-C. In addition, sequence of the targeted locus confirmed the presence of loxP site and correction of the R841X-causing mutation.
Differentiation to NPCs. NPCs were generated using dual SMAD and Wnt inhibition with manual isolation of neuronal rosettes [54] [55] [56] . Briefly, iPSC colonies were digested with collagenase IV (1 mg ml −1 ) until they lifted off the plate. Subsequently, the colonies were grown as free-floating cellular aggregates for 4 d in EB media (20% KO serum replacement, DMEM/F12, 1× NEAA, 1× penicillin/ streptomycin, 20 ng ml −1 bFGF), after which they were adhered to a matrigel-coated plate (1/71) and grown for an additional 4 d in N2B27 media (DMEM/F12, N2 1×, B27 1×, 1× non-essential amino acids, 1× penicillin/streptomycin, 20 ng ml −1 bFGF). For the first 8 d of differentiation, the cells were grown in the presence of SB431542 (10 μM) and dorsomorphin (2.5 μM). The cells were additionally treated with XAV939 (2 μM) during the first 4 or 8 d of differentiation, depending on the cell line, to facilitate more efficient differentiation. After 8 d, neural rosettes were lifted by a brief incubation (3-5 min) with Dispase and tapping, washed with PBS, and adhered to another matrigel-coated plate and fed with N2B27 media. Following that, secondary or tertiary rosettes were manually dissected to purify NPCs. NPCs were then expanded and frozen in 10% DMSO/90% N2B27 media. NPCs were characterized by immunocytochemistry for expression of NPC marker SOX1 and neural crest marker AP2 using the ThermoFisher Cellomics automated imaging and analysis platform. NPCs were seeded at a density of 15,000 per well of a 96-well Greiner microclear plate. IMR-90 fibroblasts were used as a negative control and seeded at a density of 10,000 cells per well. Using a customized TargetActivation algorithm, DAPI nuclei were detected and defined as SOX1 and AP2 positive if the average intensity of signal was greater than that observed in 99% of IMR-90 fibroblasts. Only NPC cultures with 60% SOX1
+ cells and less than 5% AP2 + cells were used for subsequent differentiation into neurons and phenotyping.
Neuronal differentiation. NPCs were seeded at a density of roughly 1,000 cells per mm 2 (1,000,000 cells per well of a 6-well plate) on matrigel-coated plastic plates (matrigel concentration 4× that used for iPSC, as determined by the dilution factor supplied by Corning with each matrigel batch). The cells were fed with neuronal differentiation (ND) medium (Neurobasal, 1× N2, 1× B27, 1× glutamax, 1× penicillin/streptomycin, 1/500 laminin) supplemented with ascorbic acid (200 nM), BDNF (10 ng μl ), and cAMP (10 μM) every other day by changing all of the medium in a given well. For days 10-14, the cultures were treated with 5 μM DAPT to attempt to curb excess NPC proliferation and promote differentiation ( Fig. 1 and Supplementary Fig. 3 ).
Sparse-seeding coculture. To begin neuronal differentiation, NPCs were seeded at 1 million cells per well of a 6-well matrigel-coated plate, as above, with 1 well per line per color. Nine to twelve wells of lawn NPCs (CTRL1 line no. 2 was used as the lawn; see Supplementary Tables 3-6) were seeded at the same time. For the first 4 weeks, the cells were fed as above. At day 21, neurons were infected with virus bearing different fluorescent colors (for example, CaMKIIα-GFP for ASD and CaMKIIα-mKO2 or CaMKIIα-mKate2 4 for control cells; 10 µl virus per well from a standard preparation, see Virus preparation). At this time, an appropriate number of vials of mouse astrocytes were thawed into a T-75 flask such that at least 1.25 million astrocytes would be present at day 26. At day 26, astrocytes at a minimum density of 250 cells per mm 2 (~50,000 per well of 24-well plate) were seeded on poly-L-ornithine and laminin-coated coverslips (12 mm in diameter) or coated plastic wells. At day 27, neurons of the lawn were digested with Accutase for 15 min, carefully triturated using a Gilson P1000 pipetman a maximum of 15 times, washed with PBS, counted, and seeded at a density of at least 1,000 cells per mm 2 (200,000 cells per well of a 24-well plate). Neuronal clumps were not removed at this stage to ensure that there were enough cells of the lawn to seed. On day 28, infected neurons were digested with Accutase for 15 min, carefully triturated using a Gilson P1000 pipetman a maximum of 15 times, strained with a 70-µm cell strainer to remove clumps, washed with PBS, and counted. After counting, each infected neuronal line was diluted to a concentration of 200,000 cells per ml, and equal volumes of lines to be compared with each other were combined into desired comparisons and seeded onto the lawn. To account for error associated with efficiency of differentiation, infection, pipetting, and counting, 3 coverslips were seeded per comparison, with 2,000, 4,000, or 6,000 cells (1%, 2%, or 3% of total neuron number) per line. Over the following week, the coverslips were monitored-those where there were at least 10 visible cells per line that were seeded sparsely enough so as to facilitate acquisition of images of full individual neurons were kept. Following reseeding, the cocultured neurons were fed with ND medium supplemented with ascorbic acid (200 nM) or with ascorbic acid and BDNF (10 ng ml
) by replacing half of the medium every other day. See Supplementary code file for the unnormalized and normalized connectivity data for every neuron for imaging (n = 601) and electrophysiology experiments (n = 680), respectively. These files will contain information regarding which lines were cocultured together for each experiment (Supplementary Tables 3 and 4) , as well as other relevant metadata.
Pharmacological screen using SparCon. Neurons from R841X no. 5 and R841X-C lines were differentiated to 4 weeks and reseeded for SparCon as above. For the following 5 weeks, they were grown in the presence of either DMSO or a pharmacological agent, such as IGF1 (20 ng μl −1 ), BDNF (20 ng μl −1
), rapamycin (10 nM), TG003 (20 µM), eFT508 (10 nM), or DHPG (100 µM).
Validation of SparCon. See Statistics section.
Dendrite extension assay. NPCs from R841X no. 2, no. 5, and no. 13, and CTRL1, CTRL2, and CTRL3 were differentiated as neuronal monocultures as described above in 24-well-plates. At 41 d of differentiation, they were transfected with an EF1α-EGFP-expressing plasmid (500 ng plasmid and 2.5 μl lipofectamine 2000 in 50 μl Opti-MEM for 1 h added to well), followed by washing twice with PBS with Ca 2+ and Mg 2+ and reimmersion in 500 μl of ND medium, as described in "Neuronal differentiation" section. On day 42, the plates were transferred to a Nikon Biostation CT at the Centre for Commercialization of Regenerative Medicine. The wells were imaged using the ×20 fluorescence microscope of the Biostation CT, and locations of neurons were marked and stored in memory. The plates were then removed from the Biostation CT and 2 different salt solutions were added to different wells: 170 μl of 55 mM KCl (resulting in final concentration of 30 mM KCl) or 170 μl of 55 mM NaCl. The plates were then returned to the Biostation and each neuron was imaged at 25-min intervals for 24 h. Dendrite length was characterized using the Simple Neurite Tracer ImageJ (3.1.3) plugin. Pilot experiments showed that maximal increase in length in control neurons occurred at approximately 500 min poststimulation and this timepoint was used for all future comparisons. The dendrite length at 500 min was normalized to the starting dendrite length for each neuron. The relative increase in dendrite length was compared across groups using a one-way analysis of variance (ANOVA) with post-hoc Tukey's tests.
Virus preparation.
Seven million HEK293T cells were plated in a T-75 flask and grown in 10% fetal bovine serum in DMEM. The next day, cells were transfected using Lipofectamine 2000 with plasmids for gag-pol (10 µg), rev (10 µg), VSV-G (5 µg), and the target construct (15 µg, CaMKIIα-GFP or CaMKIIα-mKate2 (ref.
)
or CaMKIIα-mKO2). Next day, the medium was changed. The day after that, the medium was spun down in a high-speed centrifuge at 30,000g at 4 °C for 2 h. The supernatant was discarded and 80 µl PBS was added to the pellet and left overnight at 4 °C. The next day, the solution was triturated and distributed into 10-µl aliquots and frozen at −80 °C. As noted above, one full aliquot was used to infect neurons in one well of a six-well plate.
Astrocyte preparation. Astrocytes were prepared from postnatal day 1 CD-1 mice of unknown sex as described 57 . Before use, astrocytes were checked for mycoplasma contamination. All animal work was approved by The Hospital for Sick Children Animal Care Committee and complies with the guidelines established by The Canadian Council of Animal Care.
Cloning. gRNAs were cloned into the gRNA cloning plasmid (Addgene, catalog no. 41824) by following option B in the instructions supplied with the plasmid 58 . gRNAs were designed using the CRISPR Design Tool on the Zhang Lab website (http://crispr.mit.edu) 59 . The CaMKIIα-mKO2 plasmid is described in a recent publication 11 . Western blot. Protein was extracted from cells grown in 6-well plates by washing the cells 2 times with ice-cold PBS, followed by immersion in RIPA buffer (150 mM sodium chloride, 1.0% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) with a cOmplete Mini protease inhibitor. The cells in RIPA buffer were kept on ice for 10 min and vortexed every 2-3 min. After 10 min, the samples were sonicated on a Fisher Scientific sonic dismembrator F-60 and stored at −80 °C. Proteins were quantified using the BioRad DC Assay kit. At least 20 µg of protein was loaded per sample per lane of a BOLT 4-12% gradient gel loaded into a BOLT mini gel tank. Proteins were transferred overnight onto nitrocellulose membrane at 60 V. The membranes were blocked in either 5% BSA in Tris-buffered saline with 0.05% Tween 20 (TBS-T) or 5% milk in phosphatebuffered saline with 0.05% Tween 20 (PBS-T) for 1 h at room temperature (22 °C). The membranes were then incubated with primary antibodies (1:1,000 to 1:5,000 dilution depending on antibody) overnight at 4 °C. The following day, the membranes were washed 3 times for 5 min and incubated with HRP-conjugated secondary antibodies (1:5,000) for 1 h at room temperature. The membranes were then washed 3 times for 5 min. To visualize protein, either SuperSignal West Pico Chemiluminescent Substrate (used for loading controls) or SuperSignal West Femto Maximum Sensitivity Substrate (used for all other proteins) was applied to the membrane as evenly as possible. Shortly thereafter the membranes were exposed and imaged on a Biorad Gel Doc XR system. The resulting images were quantified using BioRad ImageLab 5.1.4 software.
Mycoplasma testing. All iPSC, NPC, IMR-90, and HEK293T cell lines were shown to be mycoplasma free every 2-3 months using a standard method 60 , except that Platinum Taq was used for the PCR reactions.
Immunocytochemistry. iPSCs and NPCs were fixed in 4% paraformaldehyde in PBS for 7 min at room temperature. The cells were then washed 3 times for 5 min with PBS, permeabilized with 0.1% Triton-X in PBS for 10 min, and blocked for 1 h in 10% donkey or goat serum in PBS (blocking solution). After blocking, the cells were incubated with primary antibodies in blocking solution overnight at 4 °C. The cells were then washed with PBS and incubated with secondary antibodies in blocking solution for 1 h. The cells were then washed 3 times in PBS or incubated with DAPI (1:1,000) in PBS and washed, if the experimental protocol required it.
Neurons were fixed by 1-min immersion in 37 °C PKS (4% paraformaldehyde in Krebs-sucrose buffer, 50 mM KCl, 1.2 mM CaCl 2 , 1.3 mM MgCl 2 , 20 mm HEPES pH 7.4, 12 mM NaH 2 PO 4 , 400 mM sucrose, 145 mM NaCl, 10 mM glucose in water) to preserve fine structure 61 followed by 10 min in ice-cold methanol. PKS was added immediately after removal of culture medium, and pipetting was done slowly to prevent dislodging cells from coverslips. The neurons were then washed 3 times for 5 min with PBS and blocked with blocking solution for 1 h at room temperature. After blocking, the cells were incubated with primary antibodies diluted in blocking solution overnight at 4 °C. The cells were washed 3 times for 5 min with PBS and incubated with secondary antibodies at room temperature for 1 h. If the goal of staining was to visualize synaptic puncta, all antibody solutions were mixed thoroughly and spun in a centrifuge at max speed for 3 min to remove antibody clumps. Coverslips were rinsed in sterile water, briefly dried with a Kimwipe, and mounted on a frosted glass slide with 7-8 µl of Prolong Gold AntiFade mounting medium. The mounted coverslips were cured in the dark at room temperature for at least 24 h before imaging.
Image acquisition. For simultaneous morphometric and synaptic connectivity analysis, we acquired images of neurons at ×400 magnification using the Nikon A1R laser scanning confocal microscope. First, we identified neurons by tracking axons to their origin. To take images of entire neurons, we acquired 4 × 4 tiled Z-stacks at 0.75-µm spacing spanning 4.5 µm total. The pinhole was widened to 2.6 Airy units, which increased speed of image acquisition by allowing to increase Z-spacing and lower pixel dwell time without sacrificing Z-resolution to the extent that would compromise colocalization of SYN1 puncta to neurites. Each tile was 512 × 512 pixels, with 10% overlap, bringing the total field of view that was acquired to ~760 × 760 µm (0.4 µm 2 per pixel). Image acquisition was done in a semiautomated manner, with manual picking of individual neurons and batch acquisition. Individual channels were acquired in sequential manner to prevent bleed-through of fluorophores. We aimed to acquire at least seven neurons per color per coverslip, acquired in separate batches. Three channels would be acquired per batch for SYN1, GFP, or mKO2. Image acquisition was done in a blinded manner. While most neurons would be acquired successfully with the above setup, we omitted those neurons with neurites that either extended in x, y, or z direction beyond the 760 × 760 × 4.5 µm 3 space, encountered regions of high cell density which resulted in blurriness, or overlapped extensively with another fluorescent cell nearby.
To image iPSCs and embryoid bodies, as well as acquire phase-contrast images of live neurons, a Leica DMI4000B microscope with a DFC 340 FX camera was used. To acquire images of fluorescent neurons costained with cortical and synaptic markers, a Zeiss Axiovert 200M epifluorescence microscope with a Hamamatsu C9100-13 EM CCD camera was used. To acquire images of NPCs and unlabeled neurons ( Supplementary Fig. 3 ), the high-throughput imaging platform ThermoFisher Cellomics VTi was used. To quantify images of NPCs, the Cellomics Target Activation algorithm was used, with thresholds defined using the IMR-90 cells as a negative control.
Synapse and morphology analysis. All analyses were completed in Fiji (ImageJ 2.0.0-rc-65/1.51w). ND2 files from the Nikon NIS Elements software (4.3) were imported using the Bio-Formats plugin with channels pseudocolored such that the fluorescent protein and synapse channels were always colored in the same way from image to image to prevent the experimenter from inadvertently deciphering the genotype of the cells. The analyses were completed on maximum intensity projections of z-stacks. For morphological analysis, the longest neurite was assumed to be an axon and not traced. Dendrites were traced and morphology was analyzed using the Simple Neurite Tracer (v.3.1.3 plugin to obtain measurements for total dendrite length and Sholl analysis with 10 µm radius). Total synapse number was quantified by counting the number of SYN1 puncta overlapping with signal from the fluorescent protein using the Cell Counter plugin (2010/12/07 version). Images in which portions of the neurons could not be unambiguously distinguished, either due to blurriness or to excessive density of nearby cells, were not analyzed. All image analysis was completed in a blinded manner.
Statistics.
No sample-size calculations were performed for experimental batches 1-5 (see Supplementary Table 5 for detailed information). Sample size was determined to be adequate based on the magnitude and consistency of measurable differences between groups. Monte Carlo simulations to estimate sample sizes required to achieve a power of 0.8 were then calculated using data from batches 1-5 and used to guide subsequent experiments (see below). The data met the assumptions of the statistical test used, and normality was formally tested. The fluorescent reporters were randomized in the SparCon assays but randomization was not used in other assays. Blinding was used in all SparCon assays, neuron morphology, and electrophysiology experiments. No animals were excluded from the analysis. Cell culture experiments that failed were excluded based on neuronal cultures that did not survive or lifted off the culture plate/coverslip by the specified experimental timepoint, or were judged to be inadequate by laboratory personnel. Inadequate cultures may have had excessive cell death, excessive contamination with unwanted cell types, or inappropriate cell density (too low to allow for robust establishment of connectivity or too high to permit adequate imaging or patch-clamp).
Statistical validation and development of SparCon. SparCon within-well normalization overcomes variability and increases statistical power. For development of the method, we aimed to characterize the variability in connectivity across batches and wells. Because we could not derive an estimate for this variability in advance, we characterized 479 neurons by imaging for total synapse number and dendrite length from batches 1-3 and 390 neurons for sEPSC frequency and amplitude from batches 4 and 5 and across 39 and 48 wells, respectively. Probability distributions were fitted to the data using the fitdistrplus (1.0-11) R package. The distribution with the lowest Akaike information criterion score was considered best fit.
To examine synaptic connectivity, we first quantified absolute numbers of synapses per neuron to explore the range of variation between batches and between wells within a batch (Supplementary Fig. 8a ). Variation was immediately evident with total synapse number per cell in batch 2 being lower and batch 3 being higher than batch 1 ( Supplementary Fig. 8a ). To minimize sources of error and facilitate comparisons across wells and batches, the SparCon setup allows relative calculations of total synapse numbers by within-well normalization. Because absolute synapse number and dendrite length in control neurons both fit lognormal distributions ( Supplementary Fig. 8b ), we normalized measurements of each neuron in a given well to the geometric mean of control neuron values in the same well. Following normalization, data across batches still fit the lognormal distribution for control neurons, but were largely devoid of systematic error ( Supplementary Fig. 8c-e) . The same held true for sEPSC frequency and amplitude of control neurons ( Supplementary Fig. 9 ). We also performed color swapping experiments that compared the same line to itself in different colors (Supplementary Tables 3 and 4) . We did not detect any reporter gene bias as normalized synapse number and dendrite length were not dependent on which fluorescent protein was expressed ( Supplementary Fig. 10a ), and the same held true for normalized sEPSC frequency and amplitude ( Supplementary Fig.  10b ). Taken together, we show that normalization of SparCon data addresses confounding sample variability, and that the reporter genes have no effect on neuronal connectivity.
Since the data fit lognormal distributions, we hypothesized that nonparametric statistical tests applied to within-well normalized data may be more suitable for subsequent calculations. We performed Monte Carlo simulations to determine which statistical test was the most sensitive and whether relative within-well normalization increased statistical power at α = 0.05. These simulations revealed that the Anderson-Darling k-samples (AD) test is more sensitive than the Kolmogorov-Smirnov and more sensitive or equal to Student's t-test for all measures ( Supplementary Fig. 11a-b) . Critically, while within-well normalization significantly improved sensitivity for all measures, the effect was most pronounced on connectivity measures, such as synapse number and sEPSC frequency. For unnormalized synapse number, 45 neurons per group are necessary to detect a 1.5-fold difference for a power >0.8 at α = 0.05, but only 20 are required after within-well normalization ( Supplementary Fig. 11c ). At this sample size of 20, skipping the normalization step requires a 1.9-fold difference to achieve a power >0.8 (Supplementary Fig. 11d) . Similarly, for sEPSC frequency, within-well normalization reduces the required sample size to detect a 2-fold difference from 55 neurons to 35. At this sample size of 35, a 2.4-fold difference is necessary to achieve a power >0.8 if the data are unnormalized. While similar trends hold true for dendrite length and sEPSC amplitude, the impact is most pronounced on synapse number and sEPSC frequency, suggesting that these two measures of connectivity are particularly susceptible to experimental variation arising from heterogeneity of iPSC-derived neuronal cultures ( Supplementary Fig. 11 ). We therefore used within-well normalization with the Anderson-Darling k-samples test to evaluate SHANK2 connectivity phenotypes.
Sparse-seeding coculture. To control for well-to-well variability, measurements of all cells in a given well were normalized to the control cells in that well. For synapse number, dendrite length, sEPSC frequency, and amplitude, normalization was done by dividing the values of all cells by the geometric mean of the controls. The standard deviation differed between control and mutant groups both before and after normalization (Supplementary Tables 7 and 9 ). Anderson-Darling k-samples test was used to compare pooled samples that were cocultured together. For Sholl analysis, normalization was done by subtracting the mean number of crossings of the controls from that of a given cell in the same well at a particular radius. The change in crossings at a particular radius was then compared. Two-way ANOVA was used to compare Sholl analysis curves between conditions. P values of less than 0.05 were considered statistically significant. All analyses were performed with 1 nature research | reporting summary The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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Sample size
No sample-size calculations were performed for neuron experimental batches 1 to 5 (see Supplementary Table 5 for detailed information). Sample size was determined to be adequate based on the magnitude and consistency of measurable differences between groups. Monte Carlo simulation to estimate sample sizes required to achieve a power of 0.8 were then calculated using data from batches 1 to 5 and used to guide subsequent experiments.
Data exclusions No animals were excluded from the teratoma analysis. Cell culture experiments that failed were excluded based on neuronal cultures that did not survive or lifted off the culture plate/coverslip by the specified experimental timepoint, or were judged to be inadequate by lab personnel. Inadequate cultures may have had excessive cell death, excessive contamination with unwanted cell types, or inappropriate cell density (too low to allow for robust establishment of connectivity or too high to permit adequate imaging or patch-clamping).
Replication
We used triplicate biological replicates (3 lines) of R841X and DEL in each differentiation batch, and multiple cover slips from each line was tested. A batch involves 3 weeks of differentiation of each line, transduction of each line with both reporter viruses to enable colour swapping, mixing at sparse frequencies with the unlabelled lawn and replating on astrocytes for maturation until week 9. Each genotype was tested in a blinded fashion on 3-12 cover slips (at least 3-5 neurons measured on each), with the exception of 2 DEL lines that were tested on 2 cover slips for the ICC. The result of these highly controlled and blinded experiments was reproducible across genotypes after normalization, and included a total of 10 separately labelled batches for the initial phenotyping, and 4 extra batches for the dendrite extension assays and IGF1/BDNF/drug testing.
Randomization The fluorescent reporters were randomized in the SparCon assays but randomization was not used in other assays.
Blinding
Investigators were blinded to the color of fluorophore used to label co-cultured cells in SparCon assays. Following establishment of co-culture with differentially labeled controls and wild-types, all subsequent sample processing and data acquisition for neuronal morphology and electrophysiology was performed by blinded investigators. For monoculture experiments (e.g., RNA-Seq), investigators were not blinded. Data reported for these experiments is not subjective, but based on data acquisition and analysis approaches established in literature.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. Authentication confirmed using PCR and restriction enzyme digest, and Sanger sequencing. Whole genome sequencing of CTRL1, SHANK2 knockout, R841X, and R841X-C were also used to confirm authentication of those cell lines.
Mycoplasma contamination All cell lines tested negative for mycoplasma contamination.
Commonly misidentified lines (See ICLAC register) There were no commonly misidentified cell lines used in these experiments.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals 6 week NOD/SCID female mice (Jackson Laboratory #001303) were used to test iPSC pluripotency by teratoma assays and postnatal day 1 CD1 mice of unknown sex (SickKids in-house colony) were used to isolate astrocytes for cocultures with iPSC derived neurons.
Wild animals
No wild animals used
Field-collected samples
No samples collected from the field
Ethics oversight
All procedures on animals were approved by the SickKids Animal Care Committee.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
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Population characteristics
Individuals and their associated genotypic information are described in Supplementary Figure 1 , as well as previously published reports (Berkel et al. 2010 , Nature Genetics which contains detailed neuropsychological testing results from both children with SHANK2 mutations in this study; also Leblond et al. 2012 PLoS Genetics and Yuen et al. 2017 Nature Neuroscience ).
Recruitment
Participants for the original genetic studies from which SHANK2-mutation carriers were identified was based on family enrollment (ASD affected individuals, their parents, and in some cases affected and unaffected siblings) anchored in the Autism Speaks Autism Genetic Research Exchange protocols as part of the Autism Speaks MSSNG project (PMID: 28263302). The incremental technologies of microarray, exome sequencing, and ultimately whole genome sequencing were used to identify genetic variants under a genome-wide discovery design, and from these findings the two most relevant SHANK2 mutations in males for functional studies were collected. Subject age is not disclosed as it could lead to identification. Key papers published describing this process are Yuen et al 2017 Nature Neuroscience, and Berkel et al 2010 Nature Genetics.
Ethics oversight
All pluripotent stem cell work was approved by the Canadian Institutes of Health Research Stem Cell Oversight Committee. With approval from the SickKids Research Ethics Board, we obtained dermal fibroblasts from skin-punch biopsies at the Hospital for Sick Children, after informed consent was obtained from all subjects.
